MCED Testing Enters New Diagnostic Realms

Elie Dolgin • August 4, 2023

Real-world performance data and trial results in symptomatic individuals continue to validate the promise of screening for multiple cancers with a single blood draw. However, some worry about the performance of GRAIL's commercially available multicancer early detection test in certain high-risk groups that were not the focus of early clinical development efforts.

Continue reading at Cancer Discovery.

Yellow rings of DNA amidst white chromosomes
By Elie Dolgin September 11, 2025
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Artificially colored pancreatic islet cells
By Elie Dolgin September 5, 2025
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.